openPR Logo

Press Releases from Biotechnology by CMI (12 total)

Multiple Sclerosis Therapeutics Market to Surpass US$ 24.4 Billion by 2025

Multiple Sclerosis Therapeutics Market – Offering Long-term Disease Management Multiple sclerosis (MS) is a disabling autoimmune disease affecting the brain and the spinal cord, eventually causing nerve deterioration or permanent damage. The types of MS include relapsing-remitting MS (RRMS), primary progressive MS (PPMS) and secondary progressive MS (SPMS). RPMS is the most common type characterized by defined attacks with increasing neurological symptoms, PPMS is the rare form characterized by gradual progression

Ebola Vaccine Market - Global Industry Insights, 2017-2025

Increasing number of Ebola cases in affected regions and new vaccine development for this are expected to be factors driving growth of the market Increasing mortality rates due to Ebola is expected to be a major factor for growth of the market. According to World Health Organization, in January 2018, around 50% people infected with EVD, have died. African countries such as Siberia, Sierra Leone, Guinea, Democratic Republic of Congo, Senegal,

Oncology Biosimilars Market-Opportunity Analysis, 2017-2025

Biosimilar is a biological product that resembles a reference product and is not difference from the already approved reference product. These are relatively cheaper than branded or approved products. Several biologics for oncology have already lost their patents, and some are in its period of expiry. As more products are expected to lose patents, biosimilar is expected to gain popularity. Leading generic players such as Mylan N.V., Teva Pharmaceutical Industries

Kidney Transplant Holds The Maximum Share Of Organ Transplant Market Due To Risi …

Organ transplantation is the surgical operation in which a healthy organ is removed from one person and transplanted to another person whose organ is failed or damaged. In the organ transplantation, the donated organ may be from living donor, deceased donor, or from an animal. Whereas in some cases an artificial organ is used in the transplantation procedure. Organ transplantation gives new life to the individual with damaged or failed

Orthobiologics Market - Global Industry Insights, Trends, Outlook, and Opportuni …

Orthobiologics are substances used to heal injuries such as fractures and injured muscles, ligaments, and tendons within a short period of time. Orthobiologics are made from substances that naturally occur in the body. Some examples of orthobiologics are bone grafts, autologous blood, autologous conditioned serum, platelet rich plasma, growth factors, and stem cells. Increasing prevalence of injury and facture due to falls and road accidents are expected to augment growth of

Important Players Present In The Hematopoietic Stem Cell Transplantation Market

Hematopoietic stem cell transplantation is a procedure in which multipotent hematopoietic stem cells sourced from peripheral blood cells, bone marrow or umbilical cord blood are transplanted into a patient. Hematopoietic stem cell transplantation is commonly used in the treatment of lymphoma (Hodgkin, Non-Hodgkin), leukemia, multiple myeloma, thalassemia, sickle cell anemia, and osteoporosis. It includes two transplantation sources namely, autologous that uses stem cells from the patient’s own body and allogeneic

Targeted Cancer Therapies Market - Global Industry Insights, Trends, Outlook, an …

Targeted cancer therapies are drugs which block the growth and proliferation of cancer by interfering with specific molecules such as DNA or proteins, which are involved in the growth or expansion of cancerous cells. Targeted cancer therapies differ in several ways from standard chemotherapy. Standard chemotherapy act on all rapidly dividing cancerous cells as well as normal cells, while targeted cancer therapies act on specific molecular targets that are associated

Platelet Rich Plasma Market - Global Industry Insights, and Opportunity Analysis …

Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its

Drug Analysis and DNA Profiling to Underpin Growth of Forensic Technologies and …

The Global Forensic Technologies and Services Market was valued at US$ 10,035.1 million in 2015 and is projected to expand at a CAGR of 12.4% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Rise in crime activities globally will fuel demand for DNA profiling forensic services hence augment the market growth. Request a sample pdf Copy of report @ https://www.coherentmarketinsights.com/insight/request-sample/367 DNA is one

Ubiquitin Enzymes Market — Global Industry Insights, Trends, Outlook, and Oppo …

Ubiquitin enzymes, is also termed by E2 enzyme and seldom as known ubiquitin-carrier enzymes. This helps to achieve the second successive step in the ubiquitination process that aims at a protein to cut into various segments through the proteasome. The ubiquitination process firmly attaches ubiquitin, which is a short protein consisting of 76 amino acids, to a lysine deposit on the essential protein to be targeted. Once a protein gets

B-Cell Maturation Antigen (BCMA) Targeted Therapies Market - Global Industry Ins …

Multiple myeloma is an incurable disease of plasma cells, which needs some intervention by clinical researchers. However, there have been recent success in developing such therapy that can be effective in hematologic malignancies such as chimeric antigen receptor CAR-T cell therapy, which is expected to be promising in cancer treatment. However, researchers have found little success in finding a specific target antigen under CAR T-cell therapies for treating multiple myeloma.

atural Killer Cells Market - Global Industry Insights, and Opportunity Analysis, …

Natural killer cells are a form of granular lymphocytes of varying sizes that play an important role in innate immunity in the human body. They typically constitute of around 10% of total blood lymphocytes as compared to around 70% and 20% of T cells and B cells, respectively. Natural killer cells are cytotoxic in nature and are able to kill their targets cells by two different mechanisms: as antibody dependent